TrialPhase 2b Study of EVO756 in Adults With Moderate to Severe Chronic Spontaneous Urticaria (CSU)
Trial details
- Registry ID
- NCT06873516
- Phase
- Phase 2
Drug research
EVO756
Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.
Drug identity checked against registry records
A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.
Included trials
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Phase 2b Study of EVO756 in Adults With Moderate to Severe Chronic Spontaneous Urticaria (CSU)NCT06873516 | EVMN | Phase 2 | Completed | 2026-05-29Actual |
| Phase 2b Study of EVO756 in Adults With Atopic DermatitisNCT07150845 | EVMN | Phase 2 | Active not recruiting | 2026-07Estimated |
Phase 2b Study of EVO756 in Adults With Atopic Dermatitis
Trial details
- Registry ID
- NCT07150845
- Phase
- Phase 2
Regulatory dates and decisions
| No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed. |